As Rx costs continue to rise, employers are looking for solutions that deliver lower pharmacy spend. MedBen Rx clients are seeing measurable results, which has helped the service grow by an average of 41.2% annually since 2021.
And here are the results MedBen Rx has delivered:
- In 2025, MedBen Rx clients spent 25.1% less per employee than plans using other PBMs.
- Biosimilars have reduced the average monthly cost of affected medications by 78%.
- Patient assistance programs have reduced specialty drug spend by an average of 31.9%.
- Over the past five years, MedBen Rx clients have seen an average pharmacy cost trend of 4.6%, compared with 8.6% for clients using other PBMs.
MedBen Rx not only focuses on the cost of everyday drugs, but with the massive growth of specialty drugs, we develop customized formulary strategies, biosimilar programs, and patient assistance programs.
No single strategy addresses every cost driver. MedBen Rx’s broad set of solutions gives employers more flexibility as the pharmacy market continues to change. See all our pharmacy strategies by downloading our Client Report.